Hideki Hanawa

2.3k total citations
38 papers, 1.9k citations indexed

About

Hideki Hanawa is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Hideki Hanawa has authored 38 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 20 papers in Molecular Biology and 10 papers in Hematology. Recurrent topics in Hideki Hanawa's work include Virus-based gene therapy research (21 papers), RNA Interference and Gene Delivery (10 papers) and CRISPR and Genetic Engineering (10 papers). Hideki Hanawa is often cited by papers focused on Virus-based gene therapy research (21 papers), RNA Interference and Gene Delivery (10 papers) and CRISPR and Genetic Engineering (10 papers). Hideki Hanawa collaborates with scholars based in Japan, United States and Germany. Hideki Hanawa's co-authors include Arthur W. Nienhuis, Derek A. Persons, Phillip W. Hargrove, Elio F. Vanin, Amit C. Nathwani, Takashi Shimada, Esther R. Allay, Andrew M. Davidoff, Junfang Zhou and Deo Kumar Srivastava and has published in prestigious journals such as Blood, Journal of Virology and Biochemical and Biophysical Research Communications.

In The Last Decade

Hideki Hanawa

37 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideki Hanawa Japan 20 1.3k 1.2k 367 278 224 38 1.9k
Giridhara R. Jayandharan India 27 1.6k 1.2× 1.2k 1.0× 232 0.6× 174 0.6× 489 2.2× 83 2.3k
Gregory M. Podsakoff United States 14 1.7k 1.3× 1.8k 1.5× 633 1.7× 120 0.4× 258 1.2× 19 2.4k
Jenny McIntosh United Kingdom 22 1.2k 0.9× 1.1k 0.9× 441 1.2× 81 0.3× 282 1.3× 44 1.8k
Leszek Lisowski Australia 25 1.7k 1.4× 1.2k 1.0× 252 0.7× 165 0.6× 104 0.5× 80 2.3k
Xavier M. Anguela United States 17 1.7k 1.3× 1.3k 1.1× 476 1.3× 101 0.4× 205 0.9× 31 2.2k
John T. Gray United States 28 2.1k 1.7× 1.7k 1.5× 682 1.9× 182 0.7× 161 0.7× 55 2.8k
Denise E. Sabatino United States 25 1.8k 1.4× 1.8k 1.5× 739 2.0× 246 0.9× 526 2.3× 53 2.8k
Joab Camarena United States 11 2.1k 1.6× 807 0.7× 328 0.9× 267 1.0× 105 0.5× 16 2.3k
Steven J. Howe United Kingdom 27 1.9k 1.5× 1.6k 1.4× 532 1.4× 126 0.5× 61 0.3× 48 2.5k
David M. Markusic United States 26 1.5k 1.2× 1.4k 1.2× 641 1.7× 81 0.3× 298 1.3× 54 2.4k

Countries citing papers authored by Hideki Hanawa

Since Specialization
Citations

This map shows the geographic impact of Hideki Hanawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Hanawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Hanawa more than expected).

Fields of papers citing papers by Hideki Hanawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Hanawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Hanawa. The network helps show where Hideki Hanawa may publish in the future.

Co-authorship network of co-authors of Hideki Hanawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Hanawa. A scholar is included among the top collaborators of Hideki Hanawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Hanawa. Hideki Hanawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uchida, Naoya, et al.. (2013). The Chicken Hypersensitivity Site 4 Core Insulator Blocks Promoter Interference in Lentiviral Vectors. Human Gene Therapy Methods. 24(2). 117–124. 17 indexed citations
2.
3.
Yamaguchi, Hiroki, Hideki Hanawa, Naoya Uchida, et al.. (2009). Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression. Experimental Hematology. 37(6). 701–714. 17 indexed citations
4.
Hargrove, Phillip W., Hideki Hanawa, John C. Obenauer, et al.. (2008). Globin Lentiviral Vector Insertions Can Perturb the Expression of Endogenous Genes in β-thalassemic Hematopoietic Cells. Molecular Therapy. 16(3). 525–533. 90 indexed citations
5.
Ogawa, Koichi, Yukihiko Hirai, Masamichi Ishizaki, et al.. (2008). Long-term inhibition of glycosphingolipid accumulation in Fabry model mice by a single systemic injection of AAV1 vector in the neonatal period. Molecular Genetics and Metabolism. 96(3). 91–96. 28 indexed citations
6.
Kitagawa, Ryo, Shigehiro Miyachi, Hideki Hanawa, Masahiko Takada, & Takashi Shimada. (2007). Differential characteristics of HIV-based versus SIV-based lentiviral vector systems: Gene delivery to neurons and axonal transport of expressed gene. Neuroscience Research. 57(4). 550–558. 13 indexed citations
7.
Evans‐Galea, Marguerite V., Matthew M. Wielgosz, Hideki Hanawa, Deo Kumar Srivastava, & Arthur W. Nienhuis. (2007). Suppression of Clonal Dominance in Cultured Human Lymphoid Cells by Addition of the cHS4 Insulator to a Lentiviral Vector. Molecular Therapy. 15(4). 801–809. 60 indexed citations
8.
Miyake, Koichi, Hideki Hanawa, Yukihiko Hirai, et al.. (2007). Systemic Cancer Gene Therapy Using Adeno-associated Virus Type 1 Vector Expressing MDA-7/IL24. Molecular Therapy. 15(10). 1805–1811. 14 indexed citations
9.
Taguchi, Kazuhiro, Rei Ogawa, Makoto Migita, et al.. (2005). The role of bone marrow-derived cells in bone fracture repair in a green fluorescent protein chimeric mouse model. Biochemical and Biophysical Research Communications. 331(1). 31–36. 90 indexed citations
10.
Hematti, Peiman, Cole Ferguson, Rima Adler, et al.. (2004). Distinct Genomic Integration of MLV and SIV Vectors in Primate Hematopoietic Stem and Progenitor Cells. PLoS Biology. 2(12). e423–e423. 209 indexed citations
11.
Hanawa, Hideki & Takashi Shimada. (2003). Gene Therapy Vsing Retroviral Vectors. Uirusu. 53(2). 177–183. 1 indexed citations
12.
Nienhuis, Arthur W., Hideki Hanawa, Nobukuni Sawai, Brian P. Sorrentino, & Derek A. Persons. (2003). Development of Gene Therapy for Hemoglobin Disorders. Annals of the New York Academy of Sciences. 996(1). 101–111. 6 indexed citations
13.
Hanawa, Hideki, Patrick Kelly, Amit C. Nathwani, et al.. (2002). Comparison of Various Envelope Proteins for Their Ability to Pseudotype Lentiviral Vectors and Transduce Primitive Hematopoietic Cells from Human Blood. Molecular Therapy. 5(3). 242–251. 176 indexed citations
14.
Nathwani, Amit C., Andrew M. Davidoff, Hideki Hanawa, et al.. (2002). Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood. 100(5). 1662–1669. 139 indexed citations
15.
16.
Nakamura, Hiroyuki, Koiti Inokuchi, Hideki Hanawa, et al.. (2000). A case of chronic myeloid leukemia with minor bcr-abl transcript following fluorouracil therapy for esophageal carcinoma. Annals of Hematology. 79(7). 396–401. 10 indexed citations
17.
18.
Inokuchi, Koiti, Makoto Futaki, Hideki Hanawa, et al.. (1998). Establishment of a cell line with variantBCR/ABL breakpoint expressing P180BCR/ABL from late-appearing Philadelphia-positive acute biphenotypic leukemia. Genes Chromosomes and Cancer. 23(3). 227–238. 12 indexed citations
19.
Inokuchi, Koiti, Makoto Futaki, Hideki Hanawa, et al.. (1997). Heterogenous expression of bcr‐abl fusion mRNA in a patient with Philadelphia‐chromosome‐positive acute lymphoblastic leukaemia. British Journal of Haematology. 97(4). 837–840. 12 indexed citations
20.
Hanawa, Hideki, et al.. (1995). Dual Rearrangement of Immunoglobulin and T-cell Receptor Genes in a Case of Splenic Lymphoma with Villous Lymphocytes. Leukemia & lymphoma. 18(3-4). 357–360. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giridhara R. Jayandharan Breakdown of academic impact, for papers by Gregory M. Podsakoff Breakdown of academic impact, for papers by Jenny McIntosh Breakdown of academic impact, for papers by Leszek Lisowski Breakdown of academic impact, for papers by Xavier M. Anguela Breakdown of academic impact, for papers by John T. Gray Breakdown of academic impact, for papers by Denise E. Sabatino Breakdown of academic impact, for papers by Joab Camarena Breakdown of academic impact, for papers by Steven J. Howe Breakdown of academic impact, for papers by David M. Markusic
Rankless by CCL
2026